Back to Journals » Patient Preference and Adherence » Volume 11

Patient knowledge on reporting adverse drug reactions in Poland

Authors Staniszewska A, Dąbrowska-Bender M, Olejniczak D, Duda-Zalewska A, Bujalska-Zadrożny M

Received 19 July 2016

Accepted for publication 25 August 2016

Published 29 December 2016 Volume 2017:11 Pages 47—53

DOI https://doi.org/10.2147/PPA.S117572

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 4

Editor who approved publication: Dr Johnny Chen

Anna Staniszewska,1 Marta Dąbrowska-Bender,2 Dominik Olejniczak,2 Aneta Duda-Zalewska,2 Magdalena Bujalska-Zadrożny3

1Department of Experimental and Clinical Pharmacology, 2Department of Public Health, 3Department of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland

Aim: The aim of the study was to assess patient knowledge on reporting of adverse drug reactions.
Materials and methods: A prospective study was conducted among 200 patients. The study was based on an original survey composed of 15 single- and multiple-choice questions. The study involved individuals who have experienced adverse reactions as well as individuals who have never experienced any adverse reactions; people over the age of 18; literate; residing in Mazowieckie Voivodeship, who have not been diagnosed with any disease that could compromise their logical thinking skills.
Results: The respondents who lived in the city had a greater knowledge compared to the respondents who lived in the countryside (Pearson’s χ2=47.70, P=0.0013). The respondents who lived in the city were also more statistically likely to provide a correct answer to the question about the type of adverse reactions to be reported (Pearson’s χ2=50.66, P=0.012). Statistically significant associations were found between the place of residence of the respondents and the correct answer to the question about the data that must be included in the report on adverse reactions (Pearson’s χ2=11.7, P<0.0001).

Keywords: adverse reactions, medicinal products, pharmacovigilance, Mazowieckie Voivodeship

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Sleep disturbances among patients with epilepsy

Staniszewska A, Mąka A, Religioni U, Olejniczak D

Neuropsychiatric Disease and Treatment 2017, 13:1797-1803

Published Date: 10 July 2017

Acceptance of disease and lifestyle modification after diagnosis among young adults with epilepsy

Staniszewska A, Religioni U, Dąbrowska-Bender M

Patient Preference and Adherence 2017, 11:165-174

Published Date: 31 January 2017